Evaluating Clinical AI for LTC: Admin Guide
Selecting the right [clinical AI](/platform) solution is a critical decision for LTC facilities. A thorough evaluation is essential.
Key Facts
- Careful evaluation is crucial when selecting clinical AI solutions.
- Consider factors such as integration, usability, and ROI.
- Choose solutions that align with your facility's specific needs and goals.
Selecting the right clinical AI solution is a critical decision for LTC facilities. A thorough evaluation is essential. This guide provides administrators with a framework for assessing different AI solutions, considering factors such as integration, usability, and return on investment, ensuring alignment with their facility's specific needs and goals.
Integration
Assess the ease of integration with existing systems and workflows.
Usability
Evaluate the user-friendliness and training requirements of the AI solution.
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.
Return on Investment
Determine the potential ROI based on cost savings and improved outcomes.
Alignment
Ensure the solution aligns with your facility's specific needs and goals.
Conclusion
Careful evaluation is key to successful AI implementation. Choose solutions that meet your needs, improve outcomes, and provide a strong ROI. Invest wisely in AI. See how GIA® integrates into your existing EHR workflow in days.
Sources & References
- Translating AI Research into Reality: Summary of the 2025 Voice AI Symposium. Frontiers in Digital Health. DOI: 10.3389/fdgth.2026.1754426. Vanderbilt, MIT, Mayo Clinic, NIH Bridge2AI.
- Mapping the Neurophysiological Link Between Voice and Autonomic Function: A Scoping Review. 2025. Biology (MDPI). DOI: 10.3390/biology14101382.
- Scienza Health internal validation: 12.3M patients, 27B clinical events, 2,500+ speech biomarkers.
David Kaiser is the Founder and CEO of Scienza Health. He leads the development of GIA® and digitalhumanOS™, a clinically validated speech biomarker platform that screens for 46 cognitive and neurological conditions in under 5 minutes.
This content is intended for informational purposes and does not constitute medical advice. Editorially reviewed by David Kaiser, CEO of Scienza Health, for accuracy in post-acute care operations.
Frequently Asked Questions
What factors should I consider?
Integration, usability, ROI, and alignment.
How do I measure ROI?
By tracking cost savings and improved outcomes.
What questions should I ask vendors?
About integration, training, and support.
The Clinical Signal
Hear the latest episode on clinical AI screening in post-acute care.